azacitidine has been researched along with Carcinoma, Ovarian Epithelial in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 14 (93.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akers, SN; Batt, CA; Beck, A; Gnjatic, S; Griffiths, EA; James, SR; Karpf, AR; Lele, S; Matsuzaki, J; Mhawech-Fauceglia, P; Miliotto, A; Miller, A; Odunsi, K; Ritter, G; Tsuji, T; Zhang, W | 1 |
| Lin, L; Liu, PS; Ma, XP; Ma, YC; Wu, Y; Zhang, X | 1 |
| Benmaamar, R | 1 |
| Chen, Z; Li, J; Sheng, X; Tan, L; Yang, L; Zhao, Q; Zhou, Y | 1 |
| Chan, MW; Fang, YC; Hsu, MM; Huang, PY; Lee, CI; Lee, YC | 1 |
| Ahn, JH; Ju, W; Sung, HY | 1 |
| Collamat-Lai, G; Griffiths, EA; James, SR; Karpf, AR; Matsuzaki, J; Paluch, BE; Srivastava, P; Taverna, P | 1 |
| Akers, SN; Barger, CJ; Karpf, AR; Link, PA; Mhawech-Fauceglia, P; Miller, A; Odunsi, K; Zhang, W | 1 |
| Li, J; Sheng, X; Tan, L; Wang, Z; Zhou, D; Zhou, Y | 1 |
| Li, N; Qu, PP; Shi, Z | 1 |
| Bast, RC; Coleman, RL; Fu, S; Gershenson, DM; Hennessy, BT; Hu, W; Iyer, R; Kavanagh, JJ; Kurzrock, R; Levenback, CF; Markman, M; Sood, AK; Wolf, JK | 1 |
| Alvarez Secord, A; Darcy, KM; Havrilesky, LJ; Huang, Z; Hutson, A; Jewell, EL; Lee, PS; Markman, M; Muggia, F; Murphy, SK | 1 |
| Blanco-Fernández, A; Dempsey, E; Harvey, DJ; Madden, SF; Mariño, K; McCann, A; Peracaula, R; Pérez-Garay, M; Rudd, PM; Saldova, R; Struwe, WB; Watson, JA | 1 |
| Calonne, E; Delbecque, K; Delvenne, P; Deplus, R; Ennaji, MM; Fuks, F; Guenin, S; Kridelka, F; Krusy, N; Lampe, X; Mouallif, M | 1 |
| Di, W; Gu, L; Zhang, S; Zhu, J | 1 |
2 trial(s) available for azacitidine and Carcinoma, Ovarian Epithelial
| Article | Year |
|---|---|
Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.
Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cancer Vaccines; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Decitabine; DNA Methylation; Doxorubicin; Epigenesis, Genetic; Female; Gene Expression; Humans; Immunity, Humoral; Immunotherapy, Active; Long Interspersed Nucleotide Elements; Membrane Proteins; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polyethylene Glycols; T-Lymphocyte Subsets; Treatment Outcome | 2014 |
Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Carboplatin; Carcinoma, Ovarian Epithelial; Disease-Free Survival; DNA Methylation; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms | 2011 |
13 other study(ies) available for azacitidine and Carcinoma, Ovarian Epithelial
| Article | Year |
|---|---|
Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.
Topics: Azacitidine; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Decitabine; DNA Methylation; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Promoter Regions, Genetic; RNA, Messenger; Tumor Suppressor Proteins | 2014 |
Epigenetic modification boosts ovarian cancer vaccination.
Topics: Antigens, Neoplasm; Azacitidine; Cancer Vaccines; Carcinoma, Ovarian Epithelial; Combined Modality Therapy; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Membrane Proteins; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Treatment Outcome | 2014 |
Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
Topics: Azacitidine; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary; Promoter Regions, Genetic; RNA, Long Noncoding; Tumor Suppressor Protein p53 | 2014 |
FT-IR microspectrometry reveals the variation of membrane polarizability due to epigenomic effect on epithelial ovarian cancer.
Topics: Azacitidine; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Membrane; Chromatography, High Pressure Liquid; CpG Islands; Decitabine; Deoxycytidine Monophosphate; DNA Methylation; DNA, Ribosomal; Epigenomics; Female; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Spectroscopy, Fourier Transform Infrared | 2014 |
DNA hypomethylation-mediated overexpression of carbonic anhydrase 9 induces an aggressive phenotype in ovarian cancer cells.
Topics: Animals; Azacitidine; Carbonic Anhydrases; Carcinoma, Ovarian Epithelial; Decitabine; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms, Experimental; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phenotype; Promoter Regions, Genetic; RNA, Messenger | 2014 |
Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.
Topics: Animals; Antigens, Neoplasm; Azacitidine; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; DNA Methylation; Enzyme Inhibitors; Heterografts; Humans; Methyltransferases; Mice, SCID; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; T-Lymphocytes | 2015 |
DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Topics: Aged; Antigens, Neoplasm; Azacitidine; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Decitabine; Disease Progression; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Promoter Regions, Genetic; RNA, Messenger | 2015 |
[Reversal effect of 5-aza-2-deoxycytidine on the maternally expressed gene 3 promoter hypermethylation and its inhibitory effect on the proliferation of epithelial ovarian cancer cells].
Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Ovarian Epithelial; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; Female; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Promoter Regions, Genetic; RNA, Messenger | 2015 |
[E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].
Topics: Azacitidine; Cadherins; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; CpG Islands; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polymerase Chain Reaction; Promoter Regions, Genetic | 2009 |
The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study.
Topics: Azacitidine; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Promoter Regions, Genetic; Serpins; Tumor Suppressor Protein p53 | 2011 |
5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer.
Topics: Azacitidine; Carcinoma, Ovarian Epithelial; Decitabine; Female; Glycoproteins; Glycosylation; Glycosyltransferases; Humans; Methylation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polysaccharides | 2011 |
Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.
Topics: Azacitidine; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cervix Uteri; Cluster Analysis; Cytological Techniques; DNA Methylation; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Neoplasms, Glandular and Epithelial; Neoplastic Stem Cells; Nuclear Proteins; Octamer Transcription Factor-3; Ovarian Neoplasms; Promoter Regions, Genetic; Sequence Analysis, DNA; SOXB1 Transcription Factors; Trans-Activators; Uterine Cervical Neoplasms | 2012 |
Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.
Topics: Animals; Azacitidine; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Mice; Neoplasm Invasiveness; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Wnt Signaling Pathway | 2012 |